INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

7,671 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
34
HN
Holtz NaftaliChief Financial Officer
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.00M
9,172 sh
Feb 13, 2026Feb 13, 2026
Page 128 of 192
← PrevNext →
traded Feb 13, 2026
+0d
SEC Form 4

Evidence

34
BC
Bellows CliveCo-President Asset Servicing
NTRSNORTHERN TRUST CORP
Open-market sale
SELL$167K
1,148 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC Form 4

Evidence

34
HN
Holtz NaftaliChief Financial Officer
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$1.99M
6,104 sh
Feb 13, 2026Feb 13, 2026
traded Feb 13, 2026
+0dSEC Form 4

Evidence

32
RP
Restrepo Robert P JrDirector
ACTEnact Holdings, Inc.
Open-market sale
SELL$215K
5,000 sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC Form 4

Evidence

55
MK
Mitchell KateDirector
RALRalliant Corp
Open-market purchase
BUY$100K
2,350 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

51
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$19.63M
18.0K sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

47
GJ
Garnett Timothy JohnDirector
MPLTMapLight Therapeutics, Inc.
Open-market purchase
BUY$253K
14.1K sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

44
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$6.43M
5,924 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

44
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$9.77M
8,992 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

44
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$9.48M
8,708 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

44
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$6.10M
5,608 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

40
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$1.90M
1,740 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

40
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$4.16M
3,839 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

40
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$1.32M
1,215 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

39
CM
Cohn MatthewDirector
TBBKBancorp, Inc.
Open-market purchase
BUY$20K
325 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

39
CM
Cohn MatthewDirector
TBBKBancorp, Inc.
Open-market purchase
BUY$22K
355 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

38
SJ
Steinmetz JohnExec Mng Dir of Strategic Init
NBHCNational Bank Holdings Corp
Open-market purchase
BUY$1.00M
24.2K sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

36
CM
Cohn MatthewDirector
TBBKBancorp, Inc.
Open-market purchase
BUY$9,688
170 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

36
CM
Cohn MatthewDirector
TBBKBancorp, Inc.
Open-market purchase
BUY$13K
230 sh
Feb 12, 2026Feb 12, 2026
traded Feb 12, 2026
+0dSEC Form 4

Evidence

35
DJ
Darwal Michael JosephChief AI & Digital Officer
IBEXIBEX Ltd
Open-market sale
SELL$58K
1,660 sh
Feb 6, 2026Feb 12, 2026
traded Feb 6, 2026
+6dSEC Form 4

Evidence

35
KA
Kashani AliDirector, Chief Executive Officer
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$94K
9,259 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

34
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$129K
118 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

33
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$1.67M
1,540 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

33
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$2.56M
2,364 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

32
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$5.14M
205.4K sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

32
AE
Abraham EuanChief Hardware & Mftg Offcr
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$14K
1,375 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

31
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$39K
1,671 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

31
HJ
Hill Stephen J.Chief Operating Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$29K
1,236 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

30
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$987K
911 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

30
AS
Ahamad SamsheerSee Remarks
SITMSITIME Corp
Open-market sale
SELL$4.02M
9,100 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

30
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$519K
478 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

57
GM
Glibert Christian Michael10% Owner
FEEDENvue Medical, Inc.
Open-market purchase
BUY$641K
240.0K sh
Jan 14, 2026Feb 11, 2026
traded Jan 14, 2026
+28dSEC Form 4

Evidence

54
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$511K
545 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

54
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$288K
307 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

50
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Open-market purchase
BUY$1.84M
115.0K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

49
CP
Coleman Denis P.Chief Financial Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$2.69M
2,844 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

47
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$225K
240 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

47
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Open-market purchase
BUY$320K
20.0K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

46
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$784K
840 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

46
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$336K
360 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K